Novavax
-
{
- All
- News
- Videos
-
US Experts Recommend Novavax COVID-19 Vaccine
A panel of experts convened by the US drug regulator on Tuesday recommended the Novavax Covid-19 shot, a late runner in the fight against the virus that could nonetheless play a role in overcoming vaccine hesitancy.
-
Novavax's Covid Vaccine Gets Emergency Use Nod For Kids Aged 12-17 In India
Novavax Inc said on Tuesday its COVID-19 vaccine has got emergency-use authorization from the Drugs Controller General of India for children aged 12 to 17 years.
-
Serum Institute Seeks Emergency Use Approval Of Covid Vaccine Covovax In South Africa
Novavax and Serum Institute of India (SII) announced a regulatory submission to the South African Health Products Regulatory Agency for emergency use authorization (EUA) of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine
-
WHO Approves Novavax As 10th Authorised Covid Jab
The World Health Organization on Tuesday approved a Covid vaccine made by US pharma giant Novavax for emergency use, after the European Union medicines regulator gave it the green light.
-
Novavax Covid Vaccine Could Gain European, WHO Approval Next Week: Report
Novavax's covid vaccine could receive approval from Europe's drug regulator next week and subsequently an emergency use listing from the WHO, the Financial Times reported on Thursday
-
Serum Institue Of India Exports First Novavax Shot
Serum Institute of India has sent doses of COVID-19 vaccine to Indonesia, in its first export of the Novavax shot, the government said on Wednesday.
-
Novavax Covid Vaccine Gets First Authorization, "More Expected" Says CEO
Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within "weeks," its CEO said after the shot received its first emergency use authorization (EUA) from Indonesia.
-
Novavax Begins Early-Stage Trial For Combined Influenza, Covid Vaccines
US firm Novavax on Wednesday announced that it has initiated an early stage to evaluate the safety and immunogenicity of a combined flu Novavax' seasonal influenza and COVID-19 vaccines.
-
Novavax Applies For Emergency Use Approval Of Its Covid Vaccine In India
US-based vaccine maker Novavax has filed regulatory submissions for emergency use authorization in India. The submissions were made to the Drugs Controller General of India (DCGI) through its partner, Serum Institute of India (SII), which also manufa
-
Novavax May Get Approval In 2 Months, Likely To Cost More Than Covishield
The Covovax shot developed by American vaccine-maker Novavax would cost a "low single dollar" price per dose but is likely to be costlier than Covishield, company's CEO Stanley Erck said in an exclusive interview.
-
Serum Institute's Covovax Covid Vaccine Set For Trials On Children In July: Sources
The Serum Institute of India, which is preparing to produce Novavax's COVID-19 vaccine in the country under the name Covovax, plans to start trials of the vaccine on children next month, the company told NDTV on Thursday.
-
Novavax Covid Vaccine, To Be Made By Serum Institute, Shows 90% Efficacy
Novavax's COVID-19 jab is more than 90 percent effective, including against coronavirus variants, the vaccine maker said Monday after a large-scale US study.
-
Novavax Starts COVID-19 Vaccine Trials On Children Aged Between 12-17 Years
US biotech firm Novavax said Monday it had started clinical trials of its proposed Covid-19 vaccine on children, in a program that will involve up to 3,000 adolescents aged 12-17.
-
AstraZeneca, Novavax Ready To Scale Up COVID-19 Vaccine Production In Tie-Up With Serum Institute
British-Swedish pharma giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.
-
India Trial Sought for Novavax Covid Vaccine: 10 Facts
The Serum Institute of India, the world's biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of American vaccine developer Novavax's COVID-19 jab, which was found to be 89.3 per cent effective in a UK trial. It was also found to be highly effective against a variant first identified in the UK. But the positive...
-
US Experts Recommend Novavax COVID-19 Vaccine
A panel of experts convened by the US drug regulator on Tuesday recommended the Novavax Covid-19 shot, a late runner in the fight against the virus that could nonetheless play a role in overcoming vaccine hesitancy.
-
Novavax's Covid Vaccine Gets Emergency Use Nod For Kids Aged 12-17 In India
Novavax Inc said on Tuesday its COVID-19 vaccine has got emergency-use authorization from the Drugs Controller General of India for children aged 12 to 17 years.
-
Serum Institute Seeks Emergency Use Approval Of Covid Vaccine Covovax In South Africa
Novavax and Serum Institute of India (SII) announced a regulatory submission to the South African Health Products Regulatory Agency for emergency use authorization (EUA) of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine
-
WHO Approves Novavax As 10th Authorised Covid Jab
The World Health Organization on Tuesday approved a Covid vaccine made by US pharma giant Novavax for emergency use, after the European Union medicines regulator gave it the green light.
-
Novavax Covid Vaccine Could Gain European, WHO Approval Next Week: Report
Novavax's covid vaccine could receive approval from Europe's drug regulator next week and subsequently an emergency use listing from the WHO, the Financial Times reported on Thursday
-
Serum Institue Of India Exports First Novavax Shot
Serum Institute of India has sent doses of COVID-19 vaccine to Indonesia, in its first export of the Novavax shot, the government said on Wednesday.
-
Novavax Covid Vaccine Gets First Authorization, "More Expected" Says CEO
Novavax Inc expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within "weeks," its CEO said after the shot received its first emergency use authorization (EUA) from Indonesia.
-
Novavax Begins Early-Stage Trial For Combined Influenza, Covid Vaccines
US firm Novavax on Wednesday announced that it has initiated an early stage to evaluate the safety and immunogenicity of a combined flu Novavax' seasonal influenza and COVID-19 vaccines.
-
Novavax Applies For Emergency Use Approval Of Its Covid Vaccine In India
US-based vaccine maker Novavax has filed regulatory submissions for emergency use authorization in India. The submissions were made to the Drugs Controller General of India (DCGI) through its partner, Serum Institute of India (SII), which also manufa
-
Novavax May Get Approval In 2 Months, Likely To Cost More Than Covishield
The Covovax shot developed by American vaccine-maker Novavax would cost a "low single dollar" price per dose but is likely to be costlier than Covishield, company's CEO Stanley Erck said in an exclusive interview.
-
Serum Institute's Covovax Covid Vaccine Set For Trials On Children In July: Sources
The Serum Institute of India, which is preparing to produce Novavax's COVID-19 vaccine in the country under the name Covovax, plans to start trials of the vaccine on children next month, the company told NDTV on Thursday.
-
Novavax Covid Vaccine, To Be Made By Serum Institute, Shows 90% Efficacy
Novavax's COVID-19 jab is more than 90 percent effective, including against coronavirus variants, the vaccine maker said Monday after a large-scale US study.
-
Novavax Starts COVID-19 Vaccine Trials On Children Aged Between 12-17 Years
US biotech firm Novavax said Monday it had started clinical trials of its proposed Covid-19 vaccine on children, in a program that will involve up to 3,000 adolescents aged 12-17.
-
AstraZeneca, Novavax Ready To Scale Up COVID-19 Vaccine Production In Tie-Up With Serum Institute
British-Swedish pharma giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.
-
India Trial Sought for Novavax Covid Vaccine: 10 Facts
The Serum Institute of India, the world's biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of American vaccine developer Novavax's COVID-19 jab, which was found to be 89.3 per cent effective in a UK trial. It was also found to be highly effective against a variant first identified in the UK. But the positive...
